Top

Published in:

01-02-2019 | Editorial

FDG PET/CT for the diagnosis and management of infective endocarditis: Expert consensus vs evidence-based practice

Authors: Wengen Chen, MD, PhD, Vasken Dilsizian, MD, MASNC

Published in: Journal of Nuclear Cardiology | Issue 1/2019

Excerpt

Infective endocarditis can involve the native or prosthetic heart valves, intra-cardiac pacemaker lead or left ventricular assist device, and the diagnosis remains difficult and challenging. There has been a significant increase in the implantation of cardiac electronic device systems worldwide, and this growth has been accompanied by rises in device infections and hospital admissions.1 This is in part related to the aging population of these new device recipients, higher rate of comorbidities, and the emergence of drug-resistant bacteria.2 …

Sajadi MM, Chen W, Dilsizian V. Targeted bacteria-specific ¹⁸F-fluoro-maltohexaose but not fdg pet distinguishes infection from inflammation. JACC Cardiovasc Imaging 2018. https://doi.org/10.1016/j.jcmg.2018.03.008.CrossRefPubMed

Mind HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009—a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol 2011;34:1013-27.CrossRef

Hill EE, Herijgers P, Claus P, Vanderschueren S, Peetermans WE, Herregods MC. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: A 5-year study. Am Heart J 2007;154:923-8.CrossRef

Chen W, Kim J, Molchanova-Cook OP, Dilsizian V. The potential of FDG PET/CT for Early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue. Curr Cardiol Rep 2014;16:459-66.CrossRefPubMed

Murphy DJ, Din M, Hage FG, Reyes E. Guidelines in review: Comparison f ESC and AHA guidance for the diagnosis and management of infective endocarditis in adults. J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-1333-5.CrossRefPubMedPubMedCentral

Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-128.CrossRefPubMed

Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the american heart association. Circulation 2015;132:1435-86.CrossRefPubMed

Dilsizian V, Bacharach SL, Beanlands SR, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 2016;23:1187-226.CrossRef

Dilsizian V, Achenbach S, Narula J. On adding versus selecting imaging modalities for incremental diagnosis: A case-study of ¹⁸F-fluorodeoxyglucose PET/CT in prosthetic valve endocarditis. JACC Cardiovasc Imaging 2013;6:1020-1.CrossRefPubMed

10.

Chen W, Sajadi MM, Dilsizian V. Merits of FDG PET/CT and functional molecular imaging over echocardiography and ct angiography for the diagnosis of cardiac device infections. JACC Cardiovasc Imaging (in press).

11.

Orvin K, Goldberg E, Bernstine H, et al. The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis. Clin Microbiol Infect 2015;21:69-76.CrossRefPubMed

12.

Kim J, Feller ED, Chen W, Dilsizian V. FDG PET-CT imaging for LVAD associated infections. JACC Cardiovasc Imaging 2014;7:839-42. https://doi.org/10.1016/j.jcmg.2014.04.013 CrossRefPubMed

13.

Kim J, Feller ED, Chen W, Liang Y, Dilsizian V. FDG PET/CT for early detection and localization of left ventricular assist device infection: Impact on patient management and outcome. JACC Cardiovasc Imaging 2018. https://doi.org/10.1016/j.jcmg.2018.01.024.CrossRefPubMed

14.

Gomes A, Glaudemans AWJM, Touw DJ, et al. Diagnostic value of imaging in infective endocarditis: A systematic review. Lancet Infect Dis 2017;17:e1-14.CrossRefPubMed

15.

Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular ¹⁸F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013;61:2374-82.CrossRefPubMed

16.

Pizzi MN, Roque A, Fernández-Hidalgo N, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with ¹⁸F-fluordeoxyglucose positron emission tomography/computed tomography angiography: Initial results at an infective endocarditis referral center. Circulation 2015;132:1113-26.CrossRefPubMed

17.

Salomäki SP, Saraste A, Kemppainen J, et al. ¹⁸F-FDG positron emission tomography/computed tomography in infective endocarditis. J Nucl Cardiol 2017;24:195-206.CrossRefPubMed

18.

Kestler M, Muñoz P, Rodríguez-Créixems M, et al. Role of (18)F-FDG PET in Patients with infective endocarditis. J Nucl Med 2014;55:1093-8.CrossRefPubMed

19.

Dilsizian V, Chandrashekhar Y. Distinguishing active vasculitis from sterile inflammation and graft infection: A call for a more specific imaging target. JACC Cardiovasc Imaging 2017;10:1085-7.CrossRefPubMed

20.

Rouzet F, Chequer R, Benali K, et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med 2014;55:1980-5.CrossRefPubMed

Title: FDG PET/CT for the diagnosis and management of infective endocarditis: Expert consensus vs evidence-based practice
Authors: Wengen Chen, MD, PhD
Vasken Dilsizian, MD, MASNC
Publication date: 01-02-2019
Publisher: Springer International Publishing
Published in: Journal of Nuclear Cardiology / Issue 1/2019
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-018-1398-1

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

FDG PET/CT for the diagnosis and management of infective endocarditis: Expert consensus vs evidence-based practice

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

Interventricular septum involvement with complete atrioventricular block as first manifestation in Takayasu arteritis

Molecular phenotyping of infiltrative cardiomyopathies: The future

Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis

Adenosine MPS in octogenarians: Looking safely into the future

Myocardial perfusion imaging in extreme obesity: Leveraging modern technologies to meet a modern challenge

What is this image? 2018: Image 4 result

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page